InvestorsHub Logo
Followers 93
Posts 21466
Boards Moderated 0
Alias Born 06/07/2011

Re: MaxYazger post# 10798

Monday, 01/25/2016 11:42:12 AM

Monday, January 25, 2016 11:42:12 AM

Post# of 27676
You have answered your own question, RCHA is picking up the ball where Bio dropped it

Terminated trials offers nothing to pick up. Neither does one see a large biotech taking an interest as a sponsor. Wonder why?

My bets are on the mythical trial never being registered. Or if they ever go through the motions of registering the trial, it remains open with a status of "recruiting" forever. As per the previous aborted trial of 1 patent, participants will be difficult to find.

What were the results of the control arm for the aborted previous trial being "picked up"? There was no control arm. Nothing to pick up.

Also note, the TPA dosage for the previous aborted study of 1 mg/week was a joke. Dosage is mg/m2 (or weight)/time. No matter what the efficacy of a cancer treatment drug, try to find any in use where 1 mg/week no matter the weight of the patent is given. Happy searching.

this is a lot further along than most realize



It's nowhere.

The Jewel of the Mind is Colored with the Hue of what it Imagines

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.